Production (Stage)
Burning Rock Biotech Limited
BNR
$3.56
$0.17415.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 03/31/2024 | 03/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 83.58% | -126.33% | 24.64% | 24.64% | 24.64% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -111.71% | 1,441.56% | 25.95% | 25.95% | 25.95% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -222.06% | 162.65% | -152.44% | -152.44% | -152.44% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -149.78% | 406.67% | -131.19% | -131.19% | -131.19% |
| Cash from Investing | -86.45% | 18.13% | -631.94% | -631.94% | -631.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -200.00% | -- | -- | -- |
| Cash from Financing | -- | -3,533.33% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -94.80% | 261.47% | 101.63% | 101.63% | 101.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -202.37% | 168.39% | -98.69% | -98.69% | -98.69% |